Team
Michael
G. Chaparian,
PhD, President &
Chief Scientific Officer, and co-founder of SelectX
Pharmaceuticals
Andrew Slee, PhD, Consultant, Preclinical Development
Former Senior Director of
Preclinical Pharmacology, Anti-infectives, Cardiovascular Sciences,
DuPont Pharma; Former Vice President, Pharmacology,
Enanta Pharmaceuticals
Prakash Chaturvedula, PhD, Director of Natural Products Chemistry
Chih-Cheng Chen, PhD, Head - Fermentation Laboratory
Advisors/Consultants
Arny Demain, PhD, Fellow, Charles A.
Dana Research Institute, Drew University
Former Professor of Industrial Microbiology
Department, MIT
Founder and former Head of Department of
Fermentation Microbiology at Merck & Co.
Memeber of the National Academy of
Sciences
George Drusano, MD, Albany Medical College
Co-Director, Emerging
Infections and Pharmacodynamics Laboratory
Co-Director,
Ordway Research Institute
Director, Clinical
Pharmacology Studies Unit, Albany Medical College
Senior Staff Scientist, Ordway
Research Institute
Research Physician, Wadsworth
Center, NYS Dept. of Health
James
Moe, DVM, Formerly
Vice President, Global Toxicology and Metabolism and
Chief Toxicology Officer at the Pharmacia Corporation, President of
the American College Veterinary Pathologists
Charles
Cantor, PhD, Chief
Scientific Officer, Sequenom, Inc.
Boston University
Professor of Bio-medical Engineering,
Professor of Biochemistry, School of Medicine, Codirector, Center for Advanced
Biotechnology.
Member of the National
Academy of Sciences
Board of Directors
Helmut M. Schühsler,
PhD, Chairman.
Managing Partner, TVM
Capital
Michael G. Chaparian, PhD, President, SelectX
Pharmaceuticals
Gunnar
Weikert, PhD, Chairman, Inventages Venture
Capital
Susan J. Ward, PhD
